<!DOCTYPE html><html prefix="og: http://ogp.me/ns#" lang="zh">
<!-- Mirrored from cn.nytimes.com/business/20210126/china-covid-19-vaccine-backlash/?changeLang=zh-hans by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 28 Jan 2022 14:09:12 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head><meta charset="UTF-8"><!-- Browser render  --><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"><meta name="renderer" content="webkit"><!-- End Browser render --><meta name="keywords" content=""><meta name="description" content="北京希望国产疫苗能提升中国的全球声誉，但供货迟缓、数据披露零星且效果存疑以及对西方疫苗的攻击已经损害了这种雄心壮志。国内疫情复燃也对疫苗出口构成挑战。 
"><meta id="uuid" name="uuid" content="85cee2577fb4c3802c4b25c7ed1cf969"><meta id="headline" name="headline" content="中国新冠疫苗在多国引发抵制 - 世界经济观察报中文网"><meta id="byline" name="byline" content="黄瑞黎"><meta id="date" name="date" content="2021-01-26T10:46:26.000Z"><link rel="alternate" href="index.html" hreflang="zh-Hans"><link rel="alternate" href="zh-hant/index.html" hreflang="zh-Hant"><link rel="alternate" href="https://www.nytimes.com/2021/01/25/business/china-covid-19-vaccine-backlash.html" hreflang="en-us"><link rel="canonical" href="index.html"><link rel="alternate" type="application/rss+xml" href="https://cn.nytimes.com/rss/"><meta name="apple-itunes-app" content="app-id=807498298, app-argument=nytimescn://article:85cee2577fb4c3802c4b25c7ed1cf969"><meta name="lang" property="lang" content="zh-cmn-hans"><!-- Apple IOS safari private meta --><link rel="apple-touch-icon-precomposed" sizes="144×144" href="../../../../static01.nyt.com/images/icons/ios-ipad-144x144.png"><link rel="apple-touch-icon-precomposed" sizes="114×114" href="../../../../static01.nyt.com/images/icons/ios-iphone-114x144.png"><link rel="apple-touch-icon-precomposed" href="../../../../static01.nyt.com/images/icons/ios-default-homescreen-57x57.png"><meta name="apple-mobile-web-app-title" content="中国新冠疫苗在多国引发抵制 - 世界经济观察报中文网"><meta name="apple-mobile-web-app-capable" content="yes"><!-- End Apple IOS safari private meta --><!-- Viewport and mobile --><meta name="viewport" content="width=device-width,initial-scale=1,user-scalable=no,maximum-scale=1,minimum-scale=1,minimal-ui"><!-- End viewport and mobile --><meta http-equiv="Cache-Control" content="no-siteapp"><meta name="format-detection" content="telephone=no"><meta name="HandheldFriendly" content="true"><meta name="MobileOptimized" content="320"><meta name="x5-orientation" content="portrait"><meta name="full-screen" content="yes"><meta name="x5-fullscreen" content="true"><meta name="browsermode" content="application"><meta name="x5-page-mode" content="app"><meta name="msapplication-tap-highlight" content="no"><meta property="og:title" content="中国新冠疫苗在多国引发抵制"><meta property="og:type" content="article"><meta property="og:url" content="index.html"><meta property="og:description" content="北京希望国产疫苗能提升中国的全球声誉，但供货迟缓、数据披露零星且效果存疑以及对西方疫苗的攻击已经损害了这种雄心壮志。国内疫情复燃也对疫苗出口构成挑战。 
"><meta property="og:site_name" content="世界经济观察报中文网"><meta property="article:publisher" content="https://www.facebook.com/nytimeschinese"><meta property="article:published_time" content="2021-01-26T10:46:26.000Z"><meta property="fb:pages" content="354478527979178"><meta property="fb:app_id" content="1752616314982485"><meta property="og:image" content="../../../../static01.nyt.com/images/2021/01/22/business/00virus-china-backlash-01/merlin_182594118_3d44e273-e189-492d-8a94-8d2347ab551f-articleLarge.jpg"><meta property="twitter:card" content="summary_large_image"><meta property="twitter:url" content="index.html"><meta property="twitter:title" content="中国新冠疫苗在多国引发抵制"><meta property="twitter:description" content="北京希望国产疫苗能提升中国的全球声誉，但供货迟缓、数据披露零星且效果存疑以及对西方疫苗的攻击已经损害了这种雄心壮志。国内疫情复燃也对疫苗出口构成挑战。 
"><meta property="twitter:domain" content="cn.nytimes.com"><meta property="twitter:site" content="@nytchinese"><meta property="twitter:creator" content="@nytchinese"><meta property="twitter:image:src" content="../../../../static01.nyt.com/images/2021/01/22/business/00virus-china-backlash-01/merlin_182594118_3d44e273-e189-492d-8a94-8d2347ab551f-articleLarge.jpg"><meta name="PT" content="article"><meta name="PST" content="News"><meta name="CG" content="business"><meta name="SCG" content=""><meta name="sourceApp" content="nyt-china-web"><meta name="ptime" content="20210126104626"><meta name="utime" content="20210126104626"><meta name="pdate" content="20210126"><meta name="dat" content="Jan. 26, 2021"><meta name="hdl" content="中国新冠疫苗在多国引发抵制"><meta name="byl" content="黄瑞黎"><meta name="lp" content="北京希望国产疫苗能提升中国的全球声誉，但供货迟缓、数据披露零星且效果存疑以及对西方疫苗的攻击已经损害了这种雄心壮志。国内疫情复燃也对疫苗出口构成挑战。 
"><link rel="shortcut icon" href="https://static01.nyt.com/favicon.ico"><link rel="stylesheet" href="../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/nytcn_core/style-flex.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/web/style.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/nytcn_core/article.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/slideshow/slideshow.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/cookie-banner/style.min619b.css?v=f1810d8"><title>中国新冠疫苗在多国引发抵制 - 世界经济观察报中文网</title></head><script>var js_static_path = "https://d1f1eryiqyjs0r.cloudfront.net/js";
 var imgs_static_path = "https://d1f1eryiqyjs0r.cloudfront.net/style/imgs";
 var style_static_path = "https://d1f1eryiqyjs0r.cloudfront.net/style";
 var site = 1;
 var sectionName = "business";
 var adTyp = "art";
 var cookieString = {
     "title": "您的跟踪器设置",
     "headline": "我们使用 cookie 做什么？",
     "summary": '<p>我们利用cookies和类似的技术识别您的重复访问和偏好。我们还使用它们来衡量广告系列的效果，定位广告并分析和网站流量。更多关于cookies的信息（包括如何停用），<a id="JSCookiePolicyLink" href="https://www.nytimes.com/zh-hans/privacy/cookie-policy" rel="noreferrer noopener" target="_blank" data-testid="GDPR-policy">请查看我们的“Cookie政策”</a>。</p><p>自2020年7月20日起，我们将根据您在我们服务中所访问的内容类型向您显示我们认为与您的兴趣相关的广告。您可以<a href="https://www.nytimes.com/zh-hans/privacy/cookie-policy#how-do-i-manage-trackers" rel="noreferrer noopener" target="_blank" data-testid="GDPR-objection">提出反对</a>。希望了解更多信息，请参见我们的<a href="https://nytimes.com/zh-hans/privacy/privacy-policy#we-allow-for-personalized-advertising-on-times-services" rel="noreferrer noopener" target="_blank" data-testid="GDPR-privacy">隐私政策</a>。</p><p>通过在此处点击“我接受”或者“X”，您将被视为同意使用cookies。您随时可以通过我们的Cookie政策来更改您的跟踪器偏好。</p>',
     "button": "接受",
     "trackerButton": "您的跟踪器设置",
     "rejectButton": "拒绝所有",
     "lang": 'zh-hans',
     "trackerLink": "https://www.nytimes.com/zh-hans/privacy/cookie-policy",
 };
 var purrString = {
     "button": "请勿出售我的个人信息",
     "snackbar": "你的设置已经保存在此浏览器和设备上。如果你清除了 cookie，这些设置也会被清除。",
     "snackbarError": "Something went wrong",
     "optedOutText": "我们不再出售您的个人信息",
     "CFALinkText": "California Notices",
     "purrPopupTitle": "Your request to not sell your data will be stored for this browser and device",
     "purrPopupSummary": "If you clear your cookies, your preference will be forgotten. As a California resident, you have additional rights under the California Consumer Privacy Act of 2018. While The New York Times Company does not “sell” personal information of its readers as the term “sell” is traditionally understood, “sell” under the CCPA is broadly defined. To learn more, review the text below.",
     "purrPopupButton": "DISMISS",
     "purrPopupScrollContent": '<p>The New York Times Company does not sell personal information of its readers as the term “sell” is traditionally understood. But “sell” under the CCPA is broadly defined. It includes the sharing of personal information with third parties in exchange for something of value, even if no money changes hands. For example, sharing an advertising or device identifier to a third party may be considered a “sale” under the CCPA. </p><p>To the extent The New York Times Company “sells” your personal information (as the term “sell” is defined under the CCPA), you have the right to opt-out of that “sale” on a going-forward basis at any time. To exercise this right, click the “Do Not Sell My Personal Information” link in the footer of our website or under your “Account,” which you have already done. You can also submit a request to opt-out by emailing us at privacy@nytimes.com with the subject line “California Resident - Do Not Sell.”</p><p>Once you have opted out, you will see a change to “We No Longer Sell Your Personal Information.” If you have an account with certain Times Services (specifically nytimes.com, cooking.nytimes.com, nytimes.com/crosswords, the New York Times app, the New York Times Cooking app and the New York Times Crossword app) and are logged in, we will save your preference and honor your opt-out request across browsers and devices so long as you remain logged in. If you are not logged in, or do not have an account with any Times Services listed above, your opt-out of the “sale” of personal information will be specific to the browser or device from which you have clicked “Do Not Sell My Personal Information” and until you clear your cookies (or local storage in apps) on this browser or device. </p><p>If your browser or device is using a “do not track” setting, we will detect it and honor it on that specific browser or device only. If you wish to have a “do not track” experience across all of your browsers and devices, please make sure that all of your browsers and devices are set on “do not track.”</p><p>After you opt out of the “sale” of your personal information, we will no longer “sell” your personal information to third parties (except in an aggregated or de-identified manner so it is no longer personal information), but we will continue to share your personal information with our service providers, which process it on our behalf. Exercising your right to opt out of the “sale” of your personal information does not mean that you will stop seeing ads on our sites and apps. </p><p>To opt-out of interest-based advertising as much as technically possible, go to <a href="http://www.nytimes.com/privacy/cookie-policy#how-do-i-manage-trackers" target="_blank">“How Do I Manage Trackers”</a> in our Cookie Policy. To opt out of the “sale” of your personal information from participating companies, please visit the Digital Advertising Alliance <a href="https://optout.privacyrights.info/?c=1" target="_blank">website</a> or <a href="https://www.privacyrights.info/appchoices" target="_blank">apps</a>. We do not control these opt-out mechanisms and are not responsible for their operation.</p><p>You can designate someone else to make a request on your behalf. To protect your information, we will ask for a signed permission from you authorizing the other person to submit a request on your behalf. We will contact you to verify your identity before we respond to your authorized agent’s request.<p/><p>After 12 months, we may ask you if you want to opt into the “sale” of your personal information.</p><p>For further information, please refer to our <a href="http://www.nytimes.com/privacy/privacy-policy" target="_blank">Privacy Policy.</a></p>',
     "lang": 'zh-hans'
 };
 cbSectionName = "business";
 cbByline = "黄瑞黎";</script><!-- Google Tag Manager --><script>(function(w,d,s,l,i){
     w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});
     var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';
     j.async=true;j.src='../../../../www.googletagmanager.com/gtm5445.html?id='+i+dl;
     f.parentNode.insertBefore(j,f);
 })(window,document,'script','dataLayer','GTM-KTDZV8V');</script><!-- End Google Tag Manager --><!-- chartbeat --><script type="text/javascript">var _sf_startpt=(new Date()).getTime()</script><!-- /chartbeat --><body class="news"><main class="container-fluid main clearfix"><header class="row title-bar"><div class="nav-button default" id="menuBtn"><i class="icon-bars"></i></div><h1 class="logo"><a href="/"><svg role="img" aria-label="" width="90%" height="90%"><image width="100%" height="100%" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="/d1f1eryiqyjs0r.cloudfront.net/style/imgs/mweb/nytimes-zh-hans%402x.png" src="/d1f1eryiqyjs0r.cloudfront.net/style/imgs/mweb/nytimes-zh-hans%402x.png" alt="" border="0"></image></svg></a></h1><div class="nav-button default" id="gearBtn"><i class="icon-gear"></i></div><div class="popup gear-popup"><div class="tips-container"><div class="tips-border"></div><div class="tips-inner"></div></div><div class="popup-container"><div class="popup-body"><div class="setting-title">简繁中文</div><div class="setting-option"><a href="index024e.html?changeLang=zh-hans" class="active">简体 </a><a href="index27d8.html?changeLang=zh-hant">繁体</a></div><div class="setting-title">世界经济观察报 出版语言</div><ul class="menu-list"><li><a href="https://www.nytimes.com/">ENGLISH (英语)</a></li><li><a href="https://www.nytimes.com/es/">ESPAÑOL (西班牙语)</a></li></ul><div class="setting-title">字体大小</div><div class="setting-option"><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="small"> 小</label></div><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="normal" checked="checked"> 中</label></div><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="large"> 大</label></div><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="xlarge"> 超大</label></div></div></div></div></div></header><div class="top_banner_ad" id="topad" data-target="{&quot;pos&quot;:&quot;top&quot;,&quot;adv&quot;:&quot;&quot;}"></div><div class="article-area"><div class="setting-bar row"><div class="col-4 section-title"><h3>商业与经济</h3></div><div class="col-8 setting-btns"><div class="row"><div class="col-6"><ul class="dual-btn"><li><a href="javascript:;" class="active"><span class="setting-btn-text">中文</span> <span class="setting-btn-text-mobile">中</span></a></li><li><a href="dual/index.html"><span class="setting-btn-text">中英双语</span> <span class="setting-btn-text-mobile">双语</span></a></li><li><a href="https://www.nytimes.com/2021/01/25/business/china-covid-19-vaccine-backlash.html" target="_blank"><span class="setting-btn-text">英文 <i class="icon-share-square"></i> </span><span class="setting-btn-text-mobile">英</span></a></li></ul></div><div class="col-6 share-tools-top-container"><ul class="share-tools mobile-article"><li><a href="http://v.t.sina.com.cn/share/share.php?&amp;title=%E4%B8%AD%E5%9B%BD%E6%96%B0%E5%86%A0%E7%96%AB%E8%8B%97%E5%9C%A8%E5%A4%9A%E5%9B%BD%E5%BC%95%E5%8F%91%E6%8A%B5%E5%88%B6&amp;url=https://cn.nytimes.com/business/20210126/china-covid-19-vaccine-backlash/" target="_blank"><i class="icon-weibo"></i></a></li><!-- <li> --><!-- <a href="javascript:void(0);" class="JS_shareForQrcode" data-url="https://cn.nytimes.com/business/20210126/china-covid-19-vaccine-backlash/" data-headline="%E4%B8%AD%E5%9B%BD%E6%96%B0%E5%86%A0%E7%96%AB%E8%8B%97%E5%9C%A8%E5%A4%9A%E5%9B%BD%E5%BC%95%E5%8F%91%E6%8A%B5%E5%88%B6"> --><!-- <i class="icon-wechat"></i> --><!-- </a> --><!-- </li> --><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://cn.nytimes.com/business/20210126/china-covid-19-vaccine-backlash/" trage="_blank"><i class="icon-facebook"></i></a></li><li><a href="https://plus.google.com/share?url=https://cn.nytimes.com/business/20210126/china-covid-19-vaccine-backlash/" target="_blank"><i class="icon-google"></i></a></li><li><a href="https://twitter.com/share?text=%E4%B8%AD%E5%9B%BD%E6%96%B0%E5%86%A0%E7%96%AB%E8%8B%97%E5%9C%A8%E5%A4%9A%E5%9B%BD%E5%BC%95%E5%8F%91%E6%8A%B5%E5%88%B6&amp;url=https://cn.nytimes.com/business/20210126/china-covid-19-vaccine-backlash/" target="_blank"><i class="icon-twitter"></i></a></li><li><div class="line-it-button" data-lang="zh_Hant" data-type="share-g" data-url="https://cn.nytimes.com/business/20210126/china-covid-19-vaccine-backlash/" style="display: none;"></div><script src="../../../../d.line-scdn.net/r/web/social-plugin/js/thirdparty/loader.min.js" async="async" defer="defer"></script></li><!-- <li> --><!-- <a href="javascript:void(0);" class="JS_shareForQrcode" data-url="https://cn.nytimes.com/business/20210126/china-covid-19-vaccine-backlash/" data-headline="%E4%B8%AD%E5%9B%BD%E6%96%B0%E5%86%A0%E7%96%AB%E8%8B%97%E5%9C%A8%E5%A4%9A%E5%9B%BD%E5%BC%95%E5%8F%91%E6%8A%B5%E5%88%B6"> --><!-- <i class="icon-qrcode"></i> --><!-- </a> --><!-- </li> --></ul><div class="share-btn"><i class="icon-forward"></i></div></div></div></div></div><article class="article-content font-normal"><div class="article-header"><header><small></small><h1>中国新冠疫苗在多国引发抵制</h1></header><div class="byline-row"><div class="byline-box"><div class="byline"><address>黄瑞黎</address><time pudate="2021-01-26 10:46:26" datetime="2021-01-26 10:46:26">2021年1月26日</time></div><div class="share-btn"><i class="icon-forward"></i></div></div></div></div><figure class="article-span-photo"><img src="/static01.nyt.com/images/2021/01/22/business/00virus-china-backlash-01/merlin_182594118_3d44e273-e189-492d-8a94-8d2347ab551f-master1050.jpg" width="1050" height="700" alt="巴西原住居民正在圣保罗等待接种中国科兴生物制药公司提供的疫苗。巴西官员抱怨，这家中国公司在运输疫苗和原料方面行动迟缓。"><figcaption><span>巴西原住居民正在圣保罗等待接种中国科兴生物制药公司提供的疫苗。巴西官员抱怨，这家中国公司在运输疫苗和原料方面行动迟缓。</span> <cite>Victor Moriyama</cite></figcaption></figure><div class="row"><div class="article-left"><section class="article-body"><div class="article-partial"><div class="article-body-item col-lg-5"><div class="article-paragraph">中国的新型冠状病毒疫苗本应给它带来一次地缘政治胜利，同时展示其科学实力与<a href="../../20200911/china-vaccine-diplomacy/index.html">慷慨</a>。但在一些地方，中国疫苗反而引起了强烈抵制。</div><div class="article-paragraph">巴西和土耳其的官员抱怨，中国公司<a href="https://www.nytimes.com/2021/01/18/world/americas/brazil-covid-variants-vaccinations.html">在运输疫苗和原料方面行动迟缓</a>。有关中国疫苗的披露零星而缓慢。少数流传出来的公告表明，中国的疫苗虽然被认为有效，但阻止病毒的能力不如美国制药商辉瑞(Pfizer)和莫德纳(Moderna)的疫苗。</div><div class="article-paragraph">菲律宾的一些立法者批评政府购买中国科兴疫苗的决定。在已向科兴订购了疫苗的马来西亚和新加坡，官员们不得不向本国公民保证，只有在疫苗被证明安全有效的情况下，他们才会批准使用。</div><div class="article-paragraph">“就目前而言，我不会接种任何中国的疫苗，因为没有足够的数据，”颇有影响力的新加坡外交部前官员比拉哈里·考斯甘(Bilahari Kausikan)说。他还说，只有在“一份符合规则的报告”出来后，他才会考虑中国的疫苗。<br></div><div class="article-paragraph">至少有24个国家（其中大多数是中低收入国家）与中国疫苗公司签定了购买协议，因为辉瑞和莫德纳的疫苗已被富裕国订购一空，而中国公司表示有货可供。但是，中国疫苗供货迟缓以及效果不佳的事实意味着，这些国家可能需要更长的时间才能将病毒遏制住。</div><div class="article-paragraph"><figure class="article-inline-photo large"><div class="img-box"><img src="/static01.nyt.com/images/2021/01/22/business/00virus-china-backlash-03/merlin_180151587_5936f4e4-4ffe-4406-a081-5e483bbe408e-master1050.jpg" alt="科兴在北京的一个实验室。科兴疫苗可能不像以前认为的那样有效，这个消息的披露让世界有点措手不及。" data-src="https://static01.nyt.com/images/2021/01/22/business/00virus-china-backlash-03/merlin_180151587_5936f4e4-4ffe-4406-a081-5e483bbe408e-master1050.jpg"></div><figcaption><span>科兴在北京的一个实验室。科兴疫苗可能不像以前认为的那样有效，这个消息的披露让世界有点措手不及。</span> <cite>Thomas Peter/Reuters</cite></figcaption></figure></div><div class="article-paragraph">中国官员曾希望国产疫苗能提升中国的全球声誉，但现在他们采取了守势。与此同时，中国官方媒体发起了一场针对美国疫苗的虚假宣传，质疑辉瑞和莫德纳疫苗的安全性，并将中国的疫苗宣传为更好的替代品。中国官媒还在网上发布视频，这些视频已被美国的<a href="https://www.nytimes.com/2020/07/18/health/coronavirus-anti-vaccine.html">反疫苗运动</a>分享。</div><div class="article-paragraph">官方的中国环球电视网主播刘欣在Twitter上问道，为什么外国媒体没有对德国一些接种了一次疫苗后死亡的人做“追踪报道”，尽管科学家说这些人本身患有严重疾病。中国外交部的一名主要发言人赵立坚转发了刘欣的推文。</div></div><div class="article-body-aside col-lg-3"><div id="subscribe_cont" style="margin: 0 auto;" class="container"></div></div></div><div class="big_ad" id="medium-rectangle-ad-0" data-target="{&quot;pos&quot;:&quot;mid1&quot;,&quot;adv&quot;:&quot;&quot;}"><small>广告</small></div><div class="article-partial"><div class="article-body-item col-lg-5"><div class="article-paragraph">中国疾病预防控制中心主任高福也对美国疫苗的安全性表示疑问，因为美国疫苗的研发人员使用的是新技术，而不是中国生产商采用的传统方法。<br></div><div class="article-paragraph">中国曾希望它的疫苗能证明自己已成为一个科学和外交强国。在批准紧急使用或进入后期临床试验的疫苗数量上，中国<a href="https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html">与美国不相上下</a>。国有疫苗制造商国药集团和私有的科兴都已表示，它们今年最多可生产20亿剂疫苗，这让它们对全球抗击新冠病毒的努力至关重要。<br></div><div class="article-paragraph">与辉瑞和莫德纳的疫苗不同，中国的疫苗可以在冷藏温度下保存，因此对运输来说更方便，这使得中国的疫苗在发展中国家具有吸引力。中国的疫苗已作为援助运到了巴基斯坦和菲律宾等国。</div><div class="article-paragraph">然而，中国的疫苗外交一直受不信任的困扰。许多人仍记得<a href="../../20200506/coronavirus-china-vaccine/index.html">中国的疫苗丑闻</a>。一些国家的政府仍对北京在新冠疫情暴发初期<a href="#https://cn.nytimes.com/world/20200506/backlash-china-coronavirus/">缺乏公开</a>感到愤怒。去年年初，中国向西方国家提供口罩和防护装备的努力曾遭到批评，因为有报道称中国提供的物品质量低劣，还发生了<a href="#https://cn.nytimes.com/usa/20200415/coronavirus-china-trump-donation/" title="Link: https://cn.nytimes.com/usa/20200415/coronavirus-china-trump-donation/">中国官员要求外国公开表示感谢</a>的事情。<br></div><div class="article-paragraph">YouGov本月对17个国家和地区约1.9万人进行的<a rel="noopener noreferrer" target="_blank" href="https://today.yougov.com/topics/health/articles-reports/2021/01/15/how-much-difference-does-it-make-people-where-covi">一项调查</a>显示，大多数人对中国制造的新冠病毒疫苗表示怀疑。围绕西方疫苗的虚假宣传，可能会进一步损害它的形象。<br></div><div class="article-paragraph">向巴西和土耳其等地推迟发货是最新的困难。<br></div><div class="article-paragraph"><figure class="article-inline-photo large"><div class="img-box"><img src="/static01.nyt.com/images/2021/01/22/business/00virus-china-backlash-04/merlin_181797621_43212e61-fce5-49be-9a45-c508bd26e826-master1050.jpg" alt="首批科兴疫苗已于去年12月30日运抵土耳其。" data-src="/static01.nyt.com/images/2021/01/22/business/00virus-china-backlash-04/merlin_181797621_43212e61-fce5-49be-9a45-c508bd26e826-master1050.jpg"></div><figcaption><span>首批科兴疫苗已于去年12月30日运抵土耳其。</span> <cite>Aytug Can Sencar/European Pressphoto Agency, via Shutterstock</cite></figcaption></figure></div><div class="article-paragraph">科兴最初曾向土耳其政府承诺，去年12月向该国运送1000万剂疫苗。但据土耳其卫生部长法赫尔丁·科贾(Fahrettin Koca)说，今年1月初只运来了300万剂。他没有解释造成这一差距的原因。反对派政客已就此提出了批评。据土耳其官方通讯社阿纳多卢(Anadolu)报道，差缺的疫苗剂量终于在周一抵达。</div><div class="article-paragraph">中国外交部在一份声明中提到了国内需求的问题，因为新冠病毒<a href="#https://cn.nytimes.com/china/20210114/china-covid-lockdown/">已在国内重新出现</a>。 <br></div></div><div class="article-body-aside col-lg-3"></div></div><div class="big_ad" id="medium-rectangle-ad-1" data-target="{&quot;pos&quot;:&quot;mid2&quot;,&quot;adv&quot;:&quot;&quot;}"><small>广告</small></div><div class="article-partial"><div class="article-body-item col-lg-5"><div class="article-paragraph">“当前，国内疫苗需求量巨大，”外交部的声明说。“我们在满足国内需求的同时，克服困难，想方设法，以实际行动落实习近平主席的重要宣示，与其他国家特别是发展中国家以不同方式开展疫苗国际合作，根据他们的需要，提供力所能及的支持与帮助。”</div><div class="article-paragraph">国内疫情的零星暴发也可能阻碍了生产。拒绝对此置评的科兴上周五在网上表示，正在为北京地区的一家工厂寻找工人，因为那里出现的疫情吓跑了找工作的人。</div><div class="article-paragraph">土耳其和巴西等国正在推出使用科兴疫苗的接种计划，因为西方公司不能迅速地为这些国家提供疫苗。但巴西的努力也已被推迟。巴西卫生部长爱德华多·帕祖埃洛(Eduardo Pazuello)说，中国在批准向巴西出口原材料所需文件方面行动不够迅速。</div><div class="article-paragraph">“我们正在外交层面采取有力行动，寻找阻力所在，让问题得到解决，”帕祖洛在1月17日的新闻发布会上说。<br></div><div class="article-paragraph">上周三，巴西众议院议长罗德里戈·马亚(Rodrigo Maia)对记者说，他已与中国驻巴西大使见面，后者“明确表示，不存在政治障碍，只是技术流程上出现了一点延迟”。<br></div><div class="article-paragraph">其他国家的疫苗正开始填补空白。巴西卫生部上周四宣布，此前推迟发货的200万剂牛津-阿斯利康(Oxford-AstraZeneca)的疫苗将于次日从印度运到巴西。<br></div><div class="article-paragraph"><figure class="article-inline-photo large"><div class="img-box"><img src="/static01.nyt.com/images/2021/01/22/business/00virus-china-backlash-02/merlin_182278488_b1c4f21b-5161-412b-8f14-40cb0306b29f-master1050.jpg" alt="印度尼西亚的一名卫生工作者运送装有科兴疫苗的集装箱。当地官员最初曾说，科兴疫苗的有效率为68%。" data-src="/static01.nyt.com/images/2021/01/22/business/00virus-china-backlash-02/merlin_182278488_b1c4f21b-5161-412b-8f14-40cb0306b29f-master1050.jpg"></div><figcaption><span>印度尼西亚的一名卫生工作者运送装有科兴疫苗的集装箱。当地官员最初曾说，科兴疫苗的有效率为68%。</span> <cite>Timur Matahari/Agence France-Presse — Getty Images</cite></figcaption></figure></div><div class="article-paragraph">此外，世界也对科兴疫苗可能并不像以前认为的那样有效的消息感到有点措手不及。土耳其官员曾在早些时候说，当地的临床试验显示，科兴疫苗的<a href="https://www.nytimes.com/2020/12/25/health/turkey-brazil-sinovac-coronavirus-vaccine.html">有效率为91%</a>。印度尼西亚临床试验的结果是68%。巴西的研究人员最初曾说，科兴疫苗的有效率为<a href="../../20210108/china-coronavirus-vaccine-sinovac/index.html">78%</a>。</div><div class="article-paragraph">然后，科学家在1月12日表示，如果把出现了轻微症状的人也包括进来的话，疫苗的有效率只略高于50%。这个有效率仅比世界卫生组织为疫苗设定的有效阈值高一丁点。在上周的新闻发布会上，科兴生物的首席执行官尹卫东重申，公司的疫苗预防中重症病例的有效性达100%。他说，低有效率的原因是，临床试验主要是在医务专业人员中进行的，他们比一般人群感染新冠病毒疾病的可能性更大。</div></div><div class="article-body-aside col-lg-3"></div></div><div class="big_ad" id="medium-rectangle-ad-2" data-target="{&quot;pos&quot;:&quot;mid3&quot;,&quot;adv&quot;:&quot;&quot;}"><small>广告</small></div><div class="article-partial"><div class="article-body-item col-lg-5"><div class="article-paragraph">巴西总统雅伊尔·博索纳罗(Jair Bolsonaro)是中国及其新冠病毒疫苗的批评者，他抓住这些数据大做文章。1月13日，他嘲笑了科兴疫苗的有效性，他问一名支持者：“50%算好吗？”<br></div><div class="article-paragraph">当然，中国的疫苗对许多国家有很大的吸引力。中国外交部称，已有40多个国家表示有兴趣进口中国疫苗。包括土耳其总统雷杰普·塔伊普·埃尔多安(Recep Tayyip Erdogan)和印度尼西亚总统佐科·维多多(Joko Widodo)在内的几位世界领导人已经接种了科兴疫苗。<br></div><div class="article-paragraph">但是，有关中国疫苗的零星且前后不一致的披露仍是个问题。以国药集团为例，公司曾说，其下属的北京生物制品研究所生产的一种候选疫苗的有效率为79%，但并没有披露关键细节。国药集团没有回复记者的置评请求。<br></div><div class="article-paragraph">中国的特别行政区香港已经订购了750万剂科兴疫苗，但香港官员尚未收到该公司的紧急使用申请，也没有收到该公司的任何数据。<br></div><div class="article-paragraph">“不知道这是因为他们没有生产出足够的疫苗，还是因为他们尚无将疫苗送到香港的计划，”香港政府的2019冠状病毒疫苗顾问专家委员会召集人刘泽星博士说。</div><div class="article-paragraph">数据披露在菲律宾也有问题。菲律宾已经拿得了2500万剂科兴疫苗。反对派议员里莎·洪蒂韦罗斯(Risa Hontiveros)说，罗德里戈·杜特地(Rodrigo Duterte)总统的政府“在还没有批准紧急使用，数据也前后不一致的情况下，继续把他们对中国制造疫苗的偏好强加于公众”。</div></div><div class="article-body-aside col-lg-3"></div></div><div class="big_ad" id="medium-rectangle-ad-3" data-target="{&quot;pos&quot;:&quot;mid4&quot;,&quot;adv&quot;:&quot;&quot;}"><small>广告</small></div><div class="article-partial"><div class="article-body-item col-lg-5"><div class="article-paragraph">目前被关在监狱里的参议员、反对党领袖莱拉·德利马(Leila de Lima)对政府支付给科兴的价格是每剂61美元表示愤怒，这个价格比科兴在印尼的合作伙伴支付的高出一倍多。总统府称价格被夸大了，但由于有保密协议，他们不能透露实价。<br></div><div class="article-paragraph">尽管存在不确定性，但许多人可能别无选择。<br></div><div class="article-paragraph">“我将接种中国疫苗，”土耳其医学会(Turkish Medical Association)新冠病毒疾病监测委员会成员卡伊汉·帕拉(Kayihan Pala)说。“我在等轮到我的时候，因为没有别的选择。”<br></div></div><div class="article-body-aside col-lg-3"></div></div></section><footer class="author-info"><p>Letícia Casado、Tiffany May、Elsie Chen和Jason Gutierrez对本文有报道贡献。</p><p>黄瑞黎(Sui-Lee Wee)是《世界经济观察报》北京分社记者。她报道中国近十年，关注社会议题、性别、基因监测、医疗保健以及人口和经济的交叉议题。欢迎在Twitter上关注她 <a rel="nofollow" target="_blank" href="https://twitter.com/suilee">@suilee</a>。</p><p>翻译：世界经济观察报中文网</p><p><a rel="nofollow" target="_blank" href="https://www.nytimes.com/2021/01/25/business/china-covid-19-vaccine-backlash.html">点击查看本文英文版。</a></p></footer></div></div></article><div class="container article-footer"><div class="row"><div class="col-lg-12 mobile-refer-cont" id="J_hideRefer"><div class="related-cont"><h4>相关报道</h4><ul class="refer-list"><li class="article-refer"><div class="refer-list-item"><a href="../../20200911/china-vaccine-diplomacy/index.html" title="中国在全球推行新冠疫苗外交"><div><h3 class="refer-list-headline">中国在全球推行新冠疫苗外交</h3><p class="refer-pubdate">2020年9月11日</p></div><img alt="中国在全球推行新冠疫苗外交" src="/static01.nyt.com/images/2020/09/03/world/00vaccine-diplomacy-5/00vaccine-diplomacy-5-thumbLarge.jpg" width="75" height="75"></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="#https://cn.nytimes.com/health/20201229/sinovac-covid-19-vaccine/" title="中国科兴新冠疫苗的作用原理"><div><h3 class="refer-list-headline">中国科兴新冠疫苗的作用原理</h3><p class="refer-pubdate">2020年12月29日</p></div><img alt="中国科兴新冠疫苗的作用原理" src="/static01.nyt.com/images/2020/12/28/multimedia/c29sinovac-08/c29sinovac-08-thumbLarge.jpg" width="75" height="75"></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="../../20210108/china-coronavirus-vaccine-sinovac/index.html" title="巴西称中国科兴疫苗有效率为78%"><div><h3 class="refer-list-headline">巴西称中国科兴疫苗有效率为78%</h3><p class="refer-pubdate">2021年1月8日</p></div><img alt="巴西称中国科兴疫苗有效率为78%" src="/static01.nyt.com/images/2021/01/05/business/00china-vaccine-hfo3/00china-vaccine-hfo3-thumbLarge.jpg" width="75" height="75"></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="../../20210114/chinese-vaccine-brazil-sinovac/index.html" title="巴西调降科兴疫苗有效率意味着什么"><div><h3 class="refer-list-headline">巴西调降科兴疫苗有效率意味着什么</h3><p class="refer-pubdate">2021年1月14日</p></div><img alt="巴西调降科兴疫苗有效率意味着什么" src="/static01.nyt.com/images/2021/01/12/world/12virus-briefing-brazil1/12virus-briefing-brazil1-thumbLarge-v2.jpg" width="75" height="75"></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="../../20201230/china-vaccine/index.html" title="中国批准国药集团新冠疫苗上市"><div><h3 class="refer-list-headline">中国批准国药集团新冠疫苗上市</h3><p class="refer-pubdate">2020年12月30日</p></div><img alt="中国批准国药集团新冠疫苗上市" src="/static01.nyt.com/images/2020/12/09/business/00china-vaccine-HFO3/merlin_180960321_1e42b286-fd66-495d-97fb-d75d4a9479be-thumbLarge.jpg" width="75" height="75"></a></div></li></ul></div></div><div class="col-lg-12"><div class="related hot_article"><h5 class="related-title">最受欢迎</h5><ol class="related-articles"><li><a href="#https://cn.nytimes.com/usa/20220127/computer-chip-shortage-taiwan/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>战棋推演报告称台湾半导体工厂停产可能引发中美冲突</h4><img alt="战棋推演报告称台湾半导体工厂停产可能引发中美冲突" src="/static01.nyt.com/images/2022/01/26/us/politics/26dc-wargames/merlin_177315390_5fcf8532-e370-4f81-8f99-45c6c83044f4-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/opinion/20220127/pakistan-united-states-china/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>“巴铁”军方为什么想与中国保持距离？</h4><img alt="“巴铁”军方为什么想与中国保持距离？" src="/static01.nyt.com/images/2022/01/24/opinion/21Rafiq1/21Rafiq1-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/china/20220128/china-fight-club-ending/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>《搏击俱乐部》结局遭篡改，中国审查制度再掀争议</h4><img alt="《搏击俱乐部》结局遭篡改，中国审查制度再掀争议" src="/static01.nyt.com/images/2022/01/27/multimedia/27xp-china-fightclub/27xp-china-fightclub-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/opinion/20220126/china-covid-19/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>中国追求“清零”将把国家置于灾难之中</h4><img alt="中国追求“清零”将把国家置于灾难之中" src="/static01.nyt.com/images/2022/01/25/opinion/25emanuel/25emanuel-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/sports/20220127/peng-shuai-china-australian-open/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>澳网再现“彭帅在哪里”：球员和观赛者拒绝遗忘、为其发声</h4><img alt="澳网再现“彭帅在哪里”：球员和观赛者拒绝遗忘、为其发声" src="/static01.nyt.com/images/2022/01/26/sports/26aus-china1/merlin_199503951_9c695f25-2b8e-41b4-9c97-bf91de7aa190-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/usa/20220128/selective-high-schools-brooklyn-tech/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>作为亚裔学生就读纽约精英高中，是一种什么样的体验</h4><img alt="作为亚裔学生就读纽约精英高中，是一种什么样的体验" src="/static01.nyt.com/images/2022/01/17/us/17schools-selective1/merlin_200009688_449611ef-4c11-43d4-a6f2-e74b0066acdf-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/opinion/20220127/virtual-reality-simulation/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>我们可能活在模拟现实中，人类应该多担忧这件事？</h4><img alt="我们可能活在模拟现实中，人类应该多担忧这件事？" src="/static01.nyt.com/images/2022/01/26/opinion/26manjoo-image/26manjoo-image-thumbLarge.jpg"></article></a></li><li><a href="../../20220128/olympic-sponsors-china-beijing/indexf61c.html?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>“中国是个例外”：为何国际赞助商不愿抵制北京冬奥会</h4><img alt="“中国是个例外”：为何国际赞助商不愿抵制北京冬奥会" src="/static01.nyt.com/images/2022/01/26/world/OLYMPIC-SPONSORS-01/OLYMPIC-SPONSORS-01-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/usa/20220125/gang-chen-mit-china/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>“我们在残害我们自己”：华裔教授陈刚案背后的愤怒与幻灭</h4><img alt="“我们在残害我们自己”：华裔教授陈刚案背后的愤怒与幻灭" src="/static01.nyt.com/images/2022/01/24/science/24CHEN-promo/24CHEN-promo-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/china/20220124/winter-olympics-china-beijing-xi-jinping/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>不再取悦世界：一届展现习近平全面愿景的冬奥会</h4><img alt="不再取悦世界：一届展现习近平全面愿景的冬奥会" src="/static01.nyt.com/images/2022/01/13/world/00xi-olympics-30/00xi-olympics-30-thumbLarge.jpg"></article></a></li></ol></div></div></div></div></div><footer class="row copy-footer">&copy; 2022 The World Economy Observer.<ul class="footerLinkList"><li class="footerLink"><a rel="nofollow" href="/ad/">广告</a></li><li class="footerLink"><a rel="nofollow" href="/about-us/">关于我们</a></li><li class="footerLink"><a rel="nofollow" href="/contact/">联系我们</a></li><li class="footerLink"><a rel="nofollow" href="/tos/">服务条款</a></li><li class="purr-content"></li></ul></footer><script src="/d1f1eryiqyjs0r.cloudfront.net/js/libs/require619b.js?v=f1810d8"></script><script src="/d1f1eryiqyjs0r.cloudfront.net/js/web/article.min619b.js?v=f1810d8"></script></main></body>
<!-- Mirrored from cn.nytimes.com/business/20210126/china-covid-19-vaccine-backlash/?changeLang=zh-hans by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 28 Jan 2022 14:09:12 GMT -->
</html>